Template:Did you know nominations/Clinafloxacin


 * The following is an archived discussion of the DYK nomination of the article below. Please do not modify this page. Subsequent comments should be made on the appropriate discussion page (such as |this nomination's talk page, the article's talk page or Wikipedia talk:Did you know), unless there is consensus to re-open the discussion at this page. No further edits should be made to this page.

The result was: promoted by Cwmhiraeth (talk) 06:04, 27 September 2017 (UTC)

Clinafloxacin

 * ... that the future of clinafloxacin as a new drug is less bright due to its risk of drug-induced light sensitivity? Source: "However, further progress was limited by the emergency of significant drug-related toxicities in clinical trials, namely hypoglycemia, phototoxicity, and drug interactions... Despite the very promising in vitro susceptibility profile of clinafloxacin, the future clinical role of this drug remains very clouded given its adverse effect profile." (Grayson, ML; Crowe, SM; McCarthy, JS; Mills, J; Mouton, JW; Norrby, SR; Paterson, DL; Pfaller, MA (2012). Kucers' the use of antibiotics a clinical review of antibacterial, antifungal, antiparasitic and antiviral drugs (6th ed. ed.). Boca Raton, FL: CRC Press. pp. 1542–154)
 * Reviewed: This will be my 5th DYK nomination.

5x expanded by Biochemistry&Love (talk). Self-nominated at 04:16, 13 September 2017 (UTC).


 * Symbol confirmed.svg Article is new enough (expansion is far greater than 5x from a 214-character stub and is very recent), long enough and within policy regarding neutrality, sourcing and avoidance of paraphrasing, coming in at 0.0% in Earwig's Copyvio Detector. The hook is within length and the pun makes it sufficiently interesting. QPQ requirement will be needed for future DYK nominations. Looks good to go! Alansohn (talk) 15:18, 13 September 2017 (UTC)